Literature DB >> 25987564

Pim-2 Kinase Influences Regulatory T Cell Function and Stability by Mediating Foxp3 Protein N-terminal Phosphorylation.

Guoping Deng1, Yasuhiro Nagai1, Yan Xiao1, Zhiyuan Li2, Shujia Dai3, Takuya Ohtani1, Alison Banham4, Bin Li2, Shiaw-Lin Wu3, Wayne Hancock5, Arabinda Samanta1, Hongtao Zhang1, Mark I Greene6.   

Abstract

Regulation of the extent of immune responses is a requirement to maintain self-tolerance and limit inflammatory processes. CD4(+)CD25(+)Foxp3(+) regulatory T (Treg) cells play a role in regulation. The Foxp3 transcription factor is considered a dominant regulator for Treg cell development and function. Foxp3 function itself is directly regulated by multiple posttranslational modifications that occur in response to various external stimuli. The Foxp3 protein is a component of several dynamic macromolecular regulatory complexes. The complexes change constituents over time and through different signals to regulate the development and function of regulatory T cells. Here we identified a mechanism regulating Foxp3 level and activity that operates through discrete phosphorylation. The Pim-2 kinase can phosphorylate Foxp3, leading to decreased suppressive functions of Treg cells. The amino-terminal domain of Foxp3 is modified at several sites by Pim-2 kinase. This modification leads to altered expression of proteins related to Treg cell functions and increased Treg cell lineage stability. Treg cell suppressive function can be up-regulated by either pharmacologically inhibiting Pim-2 kinase activity or by genetically knocking out Pim-2 in rodent Treg cells. Deficiency of Pim-2 activity increases murine host resistance to dextran sodium sulfate-induced colitis in vivo, and a Pim-2 small molecule kinase inhibitor also modified Treg cell functions. Our studies define a pathway for limiting the regulation of Foxp3 function because the Pim-2 kinase represents a potential therapeutic target for modulating the Treg cell suppressive activities in controlling immune responses.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Foxp3; Pim2 kinase; autoimmunity; colitis; immunosuppression; phosphorylation; posttranslational modification (PTM); regulatory T cell

Mesh:

Substances:

Year:  2015        PMID: 25987564      PMCID: PMC4536430          DOI: 10.1074/jbc.M115.638221

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  46 in total

Review 1.  The pims and outs of survival signaling: role for the Pim-2 protein kinase in the suppression of apoptosis by cytokines.

Authors:  Eileen White
Journal:  Genes Dev       Date:  2003-08-01       Impact factor: 11.361

2.  Altered activation of AKT is required for the suppressive function of human CD4+CD25+ T regulatory cells.

Authors:  Natasha K Crellin; Rosa V Garcia; Megan K Levings
Journal:  Blood       Date:  2006-10-24       Impact factor: 22.113

3.  Transcriptional regulation by Foxp3 is associated with direct promoter occupancy and modulation of histone acetylation.

Authors:  Chunxia Chen; Emily A Rowell; Rajan M Thomas; Wayne W Hancock; Andrew D Wells
Journal:  J Biol Chem       Date:  2006-10-06       Impact factor: 5.157

4.  Analysis of FOXP3 reveals multiple domains required for its function as a transcriptional repressor.

Authors:  Jared E Lopes; Troy R Torgerson; Lisa A Schubert; Stephanie D Anover; Elizabeth L Ocheltree; Hans D Ochs; Steven F Ziegler
Journal:  J Immunol       Date:  2006-09-01       Impact factor: 5.422

5.  Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T cells.

Authors:  Samuel Huber; Christoph Schramm; Hans A Lehr; Amrit Mann; Steffen Schmitt; Christoph Becker; Martina Protschka; Peter R Galle; Markus F Neurath; Manfred Blessing
Journal:  J Immunol       Date:  2004-12-01       Impact factor: 5.422

6.  Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors.

Authors:  Harald Mikkers; Martijn Nawijn; John Allen; Conny Brouwers; Els Verhoeven; Jos Jonkers; Anton Berns
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

7.  Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas.

Authors:  G Selten; H T Cuypers; A Berns
Journal:  EMBO J       Date:  1985-07       Impact factor: 11.598

8.  Phosphorylation of FOXP3 by LCK downregulates MMP9 expression and represses cell invasion.

Authors:  Kumiko Nakahira; Akihiro Morita; Nam-Soon Kim; Itaru Yanagihara
Journal:  PLoS One       Date:  2013-10-14       Impact factor: 3.240

9.  CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade.

Authors:  P A Taylor; R J Noelle; B R Blazar
Journal:  J Exp Med       Date:  2001-06-04       Impact factor: 14.307

10.  Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease.

Authors:  S Sakaguchi; K Fukuma; K Kuribayashi; T Masuda
Journal:  J Exp Med       Date:  1985-01-01       Impact factor: 14.307

View more
  34 in total

Review 1.  Treg cells in autoimmunity: from identification to Treg-based therapies.

Authors:  Lisa Göschl; Clemens Scheinecker; Michael Bonelli
Journal:  Semin Immunopathol       Date:  2019-04-05       Impact factor: 9.623

Review 2.  Regulatory T cells in autoimmune disease.

Authors:  Margarita Dominguez-Villar; David A Hafler
Journal:  Nat Immunol       Date:  2018-06-20       Impact factor: 25.606

Review 3.  The regulation of immune tolerance by FOXP3.

Authors:  Ling Lu; Joseph Barbi; Fan Pan
Journal:  Nat Rev Immunol       Date:  2017-07-31       Impact factor: 53.106

Review 4.  The role of Pim kinase in immunomodulation.

Authors:  Zhaoyun Liu; Mei Han; Kai Ding; Rong Fu
Journal:  Am J Cancer Res       Date:  2020-12-01       Impact factor: 6.166

5.  Cimetidine down-regulates stability of Foxp3 protein via Stub1 in Treg cells.

Authors:  Yizhi Zhang; Zhoujia Chen; Xuerui Luo; Bin Wu; Bin Li; Bin Wang
Journal:  Hum Vaccin Immunother       Date:  2016-10-02       Impact factor: 3.452

Review 6.  PIM kinase inhibition: co-targeted therapeutic approaches in prostate cancer.

Authors:  Sabina Luszczak; Christopher Kumar; Vignesh Krishna Sathyadevan; Benjamin S Simpson; Kathy A Gately; Hayley C Whitaker; Susan Heavey
Journal:  Signal Transduct Target Ther       Date:  2020-01-31

Review 7.  Regulatory T Cell Plasticity and Stability and Autoimmune Diseases.

Authors:  Runze Qiu; Liyu Zhou; Yuanjing Ma; Lingling Zhou; Tao Liang; Le Shi; Jun Long; Dongping Yuan
Journal:  Clin Rev Allergy Immunol       Date:  2020-02       Impact factor: 8.667

Review 8.  Tumor-infiltrating regulatory T cells: origins and features.

Authors:  Guoping Deng
Journal:  Am J Clin Exp Immunol       Date:  2018-10-05

9.  PIM-2 protein kinase negatively regulates T cell responses in transplantation and tumor immunity.

Authors:  Anusara Daenthanasanmak; Yongxia Wu; Supinya Iamsawat; Hung D Nguyen; David Bastian; MengMeng Zhang; M Hanief Sofi; Shilpak Chatterjee; Elizabeth G Hill; Shikhar Mehrotra; Andrew S Kraft; Xue-Zhong Yu
Journal:  J Clin Invest       Date:  2018-05-21       Impact factor: 14.808

Review 10.  Forkhead box transcription factors as context-dependent regulators of lymphocyte homeostasis.

Authors:  Dietmar M W Zaiss; Paul J Coffer
Journal:  Nat Rev Immunol       Date:  2018-11       Impact factor: 53.106

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.